Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2023

Nov 13, 2023

BUY
$16.75 - $48.98 $251,250 - $734,700
15,000 New
15,000 $308,000
Q1 2020

May 14, 2020

SELL
$26.15 - $77.24 $104,600 - $308,960
-4,000 Closed
0 $0
Q4 2018

Feb 13, 2019

BUY
$81.94 - $139.71 $81,940 - $139,710
1,000 Added 33.33%
4,000 $383,000
Q3 2018

Nov 13, 2018

BUY
$138.11 - $169.04 $414,330 - $507,120
3,000 New
3,000 $424,000

Others Institutions Holding SAGE

About Sage Therapeutics, Inc.


  • Ticker SAGE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,422,300
  • Market Cap $323M
  • Description
  • Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...
More about SAGE
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.